Immunogenicity and Developability Scoring

The gap between a protein that binds its target in vitro and one that is safe and manufacturable as a therapeutic is substantial. This capstone module of the In Silico Analysis track covers the computational scoring systems that bridge that gap — quantifying immunogenicity risk, flagging developability liabilities, and assembling those scores into a structured decision framework used in early-stage therapeutic development.

── Module 12 ・ In Silico Analysis (12 lessons)